Epigenetic regulation as a new target for breast cancer therapy.
Department of Oncology, Johns Hopkins University, Baltimore, Maryland, USA.
Vered
V
Stearns
Qun
Q
Zhou
Nancy E
NE
Davidson
D000107:Acetylation; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000235:genetics*; D002843:Chromatin / Q000737:chemistry; D019175:DNA Methylation; D044127:Epigenesis, Genetic; D047628:Estrogen Receptor alpha / Q000235:genetics / Q000502:physiology; D056572:Histone Deacetylase Inhibitors; D006657:Histones / Q000378:metabolism; D006801:Humans; D006877:Hydroxamic Acids / Q000627:therapeutic use; D018168:Receptors, Retinoic Acid / Q000235:genetics / Q000502:physiology; D000077337:Vorinostat
D002843:Chromatin; D047628:Estrogen Receptor alpha; D056572:Histone Deacetylase Inhibitors; D006657:Histones; D006877:Hydroxamic Acids; D018168:Receptors, Retinoic Acid; C082925:retinoic acid receptor beta; D000077337:Vorinostat